Good Biotech Corp., an unprecedented duck IgY(ΔFc) antibody manufacturer based in Taiwan, has successfully built up the technology platform by using ducks as bio-reactors to produce a novel IgY(ΔFc) polyclonal antibody from hyperimmune duck egg yolk. Based upon the cutting edge technology and the unique characteristics of duck IgY(ΔFc) antibody, Good Biotech Corp. gained positive results on the development of IgY(ΔFc) derived snake antivenins, digoxin immune Fab and neutralizing antibodies against pathogens of bacteria, virus etc. Without having the disadvantage & limitation of traditional horse, sheep based antibodies and in the meantime, having the advantages of highly specific, high efficacy, high productivity and safety, IgY(ΔFc) antibody can be the best candidate for the new generation of Biotherapeutics.

Abstract
